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ABSTRACT: Samples containing highly unbalanced DNA
mixtures from two individuals commonly occur both in
forensic mixed stains and in peripheral blood DNA mi-
crochimerism induced by pregnancy or following organ
transplant. Because of PCR amplification bias, the genetic
identification of a DNA that contributes trace amounts
to a mixed sample represents a tremendous challenge.
This means that standard genetic markers, namely mi-
crosatellites, also referred as short tandem repeats (STR),
and single-nucleotide polymorphism (SNP) have limited
power in addressing common questions of forensic and
medical genetics. To address this issue, we developed a
molecular marker, named DIP–STR that relies on pair-
ing deletion–insertion polymorphisms (DIP) with STR.
This novel analytical approach allows for the unambigu-
ous genotyping of a minor component in the presence of
a major component, where DIP–STR genotypes of the
minor were successfully procured at ratios up to 1:1,000.
The compound nature of this marker generates a high level
of polymorphism that is suitable for identity testing. Here,
we demonstrate the power of the DIP–STR approach on
an initial set of nine markers surveyed in a Swiss pop-
ulation. Finally, we discuss the limitations and potential
applications of our new system including preliminary tests
on clinical samples and estimates of their performance on
simulated DNA mixtures.
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Introduction
Genetic polymorphisms such as short tandem repeats (STR)
and single-nucleotide polymorphism (SNP) are commonly used
in forensic identity testing [Gill et al., 1994, 2001; Jobling and Gill,
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2004; Kayser et al., 1997; Moretti et al., 2001; Tully et al., 2001] and
medical genetics [Goate et al., 1991; Hastbacka et al., 1992; Houwen
et al., 1994; Wooster et al., 1995]. However, because of PCR-based
analytical methods, these markers have low sensitivity in character-
izing samples that contain DNA from several contributors in very
different proportions. In general, PCR fragment analysis that is not
deep sequenced allows for the detection of a minor DNA compo-
nent in a mixture only when it represents more than 10% of the
total DNA; however, the unambiguous identification of all minor
DNA alleles requires a minor DNA fraction of at least 20% [Fregeau
et al., 2003; Sutherland et al., 2009; Westen et al., 2009].
Historically, characterizing unbalanced DNA mixtures has been
associated with the analysis of biological stain for forensic identi-
fication purposes. For example, challenging mixed stains may be
derived from samples including, but not limited to, clothing, hair,
skin, or items the perpetrator may have touched. Because these
samples are likely to carry small quantities of the perpetrator’s DNA
mixed with a large amount of the victim’s DNA, the limit of resolu-
tion of currently used markers may have dramatic consequences
for justice. Moreover, several fields of medical genetics recently
expressed a paramount need for tools that enable the analysis of
unbalanced DNA mixture occurring in vivo, also referred as DNA
microchimerism (less than 1% of foreign cells). Few examples are
the DNAmicrochimerism associated to pregnancy, which is caused
by the transient circulation of minute quantities of fetal DNA in
the maternal blood [Lo et al., 1998; Tjoa et al., 2006] or the trace
quantities of donor’s DNA in the body fluids (blood and urine) of
transplanted patients [Chok et al., 2002; Gadi et al., 2006; Moreira
et al., 2009; Pujal and Gallardo, 2008].
Advances in the above medical fields all require novel analytical
approaches for the detection and quantification (specific for organ
transplant applications) of the DNA of interest when mixed to a
high foreign DNA background. A simple solution to this problem is
represented by a standard amplification-based method that targets
a genomic region unique to the minor DNA (allogeneic marker)
eliminating the masking effect of the major DNA.
Molecular markers located on the Y chromosome are the most
widely employed allogeneicmarkers for all cases ofmaleDNAdetec-
tion over high female background [Roewer, 2009]. Unfortunately,
this approach has several limitations: first, the applicability to mix-
tures with a specific sex mismatch dramatically reduces the number
of suitable cases. Second, because of the mostly nonrecombining
nature of the Y chromosome, without mutations paternally related
individual all share the same Y STR alleles. Third, since all Y STR
constitute a single haplotype, multiplying the individual allele fre-
quencies is not valid as for independently inherited autosomal STR.
Therefore, a match between Y STR profiles that is evaluated on
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the basis of haplotype frequencies may be an evidence of reduced
weight for forensic identification purposes [Vermeulen et al., 2009].
On this issue, a sequencing-based study of two Y chromosomes sep-
arated by 13 generations discovered four single-base differences in
10 Mb DNA [Xue and Tyler-Smith, 2010]. This suggests that the
Y chromosome accumulates around one mutation per generation,
which means that a sequencing-based assay should distinguish al-
most every Y chromosome. Alternatively, it was recently proposed a
locus-specific approach, which is based on the analysis of 13 rapidly
mutating Y-STRs. Although this method can be more easily ex-
ecuted, the results indicate a lower performance with about 50%
of father and sons being distinguished among 305 male relatives
[Ballantyne et al., 2012].
The human leukocyte antigen (HLA) gene variants are another
example of allogeneic markers, and are typically employed in trans-
plantation follow-up studies [Gadi et al., 2006]. Nevertheless, this
methoduses a geneticmarker that has an effect on the immunogenic
compatibility of the recipient–donor pair; therefore, it necessarily
introduces an ascertainment bias in themicrochimerismanalysis in-
duced by organ transplant. Additionally, as for the Y chromosome,
HLA variants are clustered on the same chromosome, resulting in a
decreased power of discrimination between individuals.
In peripheral blood DNA macrochimerism (usually more than
10% of foreign cells) induced by hematopoietic stem cell trans-
plantation, new assays have been proposed for all donor–recipient
type based on biallelic deletion–insertion polymorphisms (DIP)
polymorphisms and null alleles [Alizadeh et al., 2002; Jimenez-
Velasco et al., 2005]. Yet, biallelic systems are associated with a low
discrimination power which makes them sensitive to confounding
factors such as transfusions associated to the surgery, inborn mi-
crochimerism [Rubocki et al., 2001] or other possible medically
related contaminations linked to the amplification of minute quan-
tities of DNA.
Finally, great expectations are placed on the contribution of
next-generation sequencing techniques to forensic and DNA mi-
crochimerism analyses [Irwin et al., 2011; Snyder et al., 2011].
However, a recent publication indicates that caution must be taken
[Bandelt and Salas, 2012]. These authors conducted an indirect
quality assessment of a study on heteroplasmic mitochondrial DNA
mutations based on high-throughput sequencing [He et al., 2010].
By using in silico phylogenetic approaches, they found that on av-
erage at least five mutations were missed per sample. Although this
is one particular study and the error rate may dramatically reduce
with the rigorous application of quality controls and standards to
be defined, next-generation sequencing may remain of limited use
for immediate forensic applications. Cautions are mainly about:
the quantity and quality of DNA required; the persistence of PCR
bias as forensic applications is expected to use target sequencing
approaches (not whole genome); the risk of cross contamination is
due to a large number of parallel reactions; the difficulty of repeat
sequence analysis (STR) and finally; the times, costs, and expertise
required for this type of analysis [Berglund et al., 2011; Hert et al.,
2008; Metzker, 2010; Snyder et al., 2011].
With these considerations in mind, we propose here new ge-
netic markers, the DIP–STR, which are located throughout the
genome, highly polymorphic, easy to genotype, and capable of re-
solving extremely unbalanced two DNA mixtures (ratio 1:1,000).
We describe an initial set of DIP–STR markers including a pop-
ulation survey and data of their performance on both simulated
DNA mixtures and two representative clinical samples. Further, we
discuss the potential contribution of this tool to various research
fields.
Table 1. DIP–STR Marker List





MID1013a–D5S490 5q23.2 –/CCAG GT 307–343
MID1950a–D20S473 20p13 –/ATT TTA 213–231
MID1107a–D5S1980 5p15.33 –/AACA CA 650–680
rs11277790–D10S530 10q25.1 –/TCCAACT GT 344–362
rs60194384–D15S1514 15q26.2 –/TCTTAA TATC 281–309
rs67842608–D5S468 5q11.2 –/TGGTTTAA GT 379–395
rs66679498–D2S342 2q32.3 –/CCAACTTTCTCCTAC CA 340–357
rs10564579–D3S1282 3p24.1 –/GTCATA CA 714–728
rs35708668–D5S2045 5q34 –/TACTATGTAC CA 621–649
aMarker name from the Marshfield database correspond to rs1611095, rs2308142, and
rs2067195, respectively.
Methods
Database Search of DIP-Linked STR Markers
From the University of California Santa Cruz (UCSC) database
([assemblyFeb2009(GRCh37/hg19]) [Kent et al., 2002], byusing the
“Table Browser” tool, we searched for DIP polymorphisms in the
group“VariationandRepeats,” track“SNPs (131)”, region“genome”
filtered by class “in-del”, “insertion” and “deletion”; those with “un-
known” validity were excluded and we set sequence “weight” equal
to 1. About 216,000 DIP were obtained on the basis of these crite-
ria, this number still included stretches of the same base and short
nucleotide repeats, which we excluded after selection of DIP-linked
STR. From the same database, STR were selected from the group
“Mapping and Sequencing Tracks”, track “STS Markers” filtered for
the presence on the “Marshfield genetic map” by selecting those
with assigned “MarshfiledChrom” and “MarshfieldPos”, we further
eliminated those with a Marshfield chromosome assignment not
corresponding to the UCSC chromosome assignment. About 7,469
STR were selected on the basis of these criteria. The DIP character-
ized by a deletion/insertion of at least 2 bp located less than 500 bp
from an STR were about 70. To ensure the independence of markers
and to reduce the risk of linkage with disease or other phenotypic
information, we searched for candidate DIP–STR located on differ-
ent chromosomes (when possible) and in noncoding regions, which
are not clinically associated. Once an initial list of nine DIP–STR
markers was established (Table 1), we tested single-marker allelic
variability by genotyping 20 Swiss individuals under informed con-
sent.
Primer Design and PCR Conditions
Each single DIP and STR polymorphism was first independently
validated by PCR. To do so, we used the primer3 software [Rozen
and Skaletsky, 2000] for designing primers around the DIP poly-
morphisms; we used the primers indicated on the UCSC database
for the STR. The L-DIP primers were designed to include a 3′end re-
gion that was complementary to the inserted sequence, whereas the
S-DIP primer lacked the inserted sequence at the 3′end and passed
the insertion point by three to seven nucleotides (Supp. Table S1).
It should be noted that a condition for strong specificity of both S
and L primers is that the inserted sequence and the region past the
insertion point are substantially different.
Each PCR reaction was performed in a final volume of 20 µl
containing 1× PCR buffer with 1.5 mM MgCl2 (Applied Biosys-
tems, Zug, Switzerland), 250 µM of each dNTP, 1.2 U AmpliTaq
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Figure 1. A: DIP–STR informative genotypes. A DIP–STR haplotype is analyzed by using PCR primers overlapping the DIP on one side (either
L-DIP or S-DIP primer) and downstream the STR (STR primer) on the other side. When major and minor DNA contributors are opposite homozygous
LL/SS or SS/LL (“informative genotype 1”), two minor DNA haplotypes can be identified in the mixture (red box); conversely, when the major DNA
contributor is homozygous, either SS or LL, and the minor DNA contributor is heterozygous (“informative genotype 2”), one minor DNA haplotype
can be identified in the mixture (blue box). Arrows indicate PCR primers. B: Theoretical evaluation of the occurrence of informative markers.
Letter s and l indicate the allele frequencies of S and L alleles, respectively. In red are the probabilities of informative DIP genotypes enabling the
identification of two minor DNA haplotypes (“informative genotype 1”). Depending on the linked STR alleles, these are the same or different. In
blue are the probabilities of informative DIP genotypes enabling the identification of one minor DNA haplotype (“informative genotype 2”). The sum
of these values (s2l2+l2s2+2s3l+2sl3) gives the probability of having any type of informative genotype (I) in a mixture of two DNA.
Gold DNA Polymerase, 1 µM of each forward and reverse primer
and 1 ng of genomic DNA (DNA quantity varied for specificity
and limit of detection tests). The PCR thermocycling conditions
are: 5 min at 95◦C; followed by 60 sec at 94◦C, 60 sec at 52◦C, and
60 sec at 72◦C for 30 cycles and a final extension of 30 min at 72◦C.
The annealing temperature of 52◦C was modified to 58◦C when us-
ing DIP–STR primers MID1107-D5S1980 and both annealing and
extension time were 75 and 90 sec for marker MID1107-D5S1980
and rs10564579-D3S1282 and rs35708668-D5S2045. The thermal
cyclers employed are GeneAmp 9700 (Applied Biosystems, Zug,
Switzerland). Before capillary electrophoresis, 1 µl PCR product is
added to 8.5 µl deionized formamide HI-DI (Applied Biosystems,
Zug, Switzerland) and 0.5 µl GS-ROX 500 size standard (Applied
Biosystems, Zug, Switzerland). DNA fragments are separated us-
ing an ABI PRISM 3100 Genetic Analyzer (Applied Biosystems,
Zug, Switzerland) according tomanufacturer’s instruction and ana-
lyzed with GeneMapper ID v3.2 software (Applied Biosystems, Zug,
Switzerland), with minimum interpretation peak threshold of 50
relative fluorescence units (RFU).
Allele Specificity Tests
Amplification specificity, when using S-DIP and STR primers as
well as L-DIP and STR primers, was tested by amplifying 1 ng of
DNA template heterozygous for the DIP allele mixed with increas-
ing quantities of a second DNA homozygous for the opposite DIP
allele LL and SS respectively (as “informative genotype 2” in Fig.
1A), both DNA were selected irrespective of the genotype of the
linked STR. The DNA ratios tested included 1:10, 1:20, 1:50, 1:100,
and 1:1,000. One representative result is reported in Figure 2 to-
gether with the comparative analysis of the same mixture amplified
by a standard forensic kit, NGMselect (Applied Biosystems, Zug,
Switzerland) according to manufacturer’s instruction.
PCR Limit of Detection
We estimated the minimal amount of DIP heterozygous DNA re-
quired to produce a DIP–STR product detectable by capillary elec-
trophoresis, by varying the total DNA content in the PCR reaction
from 1 down to 0.025 ng. Amplifications were done in duplicate,
and the number of PCR cycles was increased to 34.
Allele Frequencies and Summary Statistics
Wegenotyped 103 Swiss unrelated individuals with the nineDIP–
STR markers of Table 1. Blood and saliva samples were taken after
informed consent and approval from the local ethic committee.
DNA was extracted by using the QIAamp DNA Mini kit (Qiagen
AG, Basel, Switzerland) according to the manufacturer’s guidelines
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Figure 2. Performance of DIP–STR and forensic STR in resolving various ratios of DNA mixtures. A: The electropherograms show the DIP–STR-
specific amplification of a minor DNA when mixed to increasing quantities (1:10 to 1:1,000) of a second DNA, both genotypes of the two-mixed
DNA are known. We report here one informative marker, rs67842608-D5S468 as a representative example. The minor DNA-specific amplification
is achieved by using the S-DIP primer, which targets the minor allele 92S (377 bp), that is not shared with the major DNA, 90L 94L (383–387 bp).
Note that the alleles of the major DNA are 375 and 379 bp long, when they are amplified by the S-DIP primer due to a nonspecific amplification. B:
The same DNA mixtures were analyzed by the forensic kit NGMselect (Applied Biosystems). We show here only four representative markers. The
electropherogram corresponding to the DNA ratio 1:10 shows that the minor DNA alleles indicated by red arrows are close to the detection limit
and they are quickly not detected anymore when the quantity of the major DNA increase to 1:20, 1:50, and so on (for 1:100 and 1:1,000 data are not
reported).
and quantified using the Quantifiler Human DNA Quantification
Kit (Applied Biosystems, Zug, Switzerland). Summary statistics of
population survey is reported in Table 2. Haplotype frequencies are
indicated in Supp. Table S2. CEPH 1347–02 DNA was genotyped
as a reference control for allele size. Its genotype is indicated at
the bottom of each marker frequency data. The marker haplotypes
are named according to the S or L allele at the DIP polymorphism
and the allele size of the linked STR marker when this is analyzed
by STR primers of Supp. Table S1. For markers MID1013-D5S490,
MID1950-D20S473, andMID1107-D5S1980, the STR allele name is
expressed in arbitrary numbers increasing according to the numbers
of STR repeats.
Clinical Samples
Blood and saliva samples were collected under informed consent
and approval from the local ethics committee, which required for










MID1013–D5S490 15 6 (0.78) 9 (0.22) 0.49 0.28
MID1950–D20S473 10 5 (0.62) 5 (0.38) 0.80 0.36
MID1107–D5S1980 13 8 (0.31) 5 (0.69) 0.74 0.34
rs11277790–D10S530 15 8 (0.81) 7 (0.19) 0.73 0.26
rs60194384–D15S1514 12 7 (0.61) 5 (0.39) 0.88 0.36
rs67842608–D5S468 13 4 (0.21) 9 (0.79) 0.62 0.28
rs66679498–D2S342 11 6 (0.65) 5 (0.35) 0.69 0.35
rs10564579–D3S1282 12 7 (0.73) 5 (0.27) 0.85 0.32
rs35708668–D5S2045 19 18 (0.96) 1 (0.04) 0.85 0.07
N, number; Obs. Het., observed heterozygosity; I, probability of informative genotypes.
the forensic sample the additional agreement of the justice office re-
sponsible of the investigation. Forensic mixed stain collected on the
body of the victim and reference samples from the victim (blood)
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Table 3. Occurrence of Informative Markers
Empirical estimate using eight DIP–STRa Expected estimate using
30 DIP–STR
Percentage of DNA mixtures (≥N informative markers)
95 (≥1) 95 (≥6)
76 (≥2) 89 (≥7)
47 (≥3) 79 (≥8)
21 (≥4) 66 (≥9)
6 (≥5) 50 (≥10)
aMarker rs35708668-D5S2045was eliminatedbecause of the extremely low information
content.
and the three suspects (saliva) were extracted with the QIAamp
DNA mini kit following manufacture’s instruction. PCR genotyp-
ing and electrophoresis were performed as indicated in the para-
graph “Primer design and PCR conditions.” We used 4 ng of total
DNA from themixed stain to amplify DIP–STRmarkers. Pregnancy
DNAmicrochimerism sampleswere obtained from2ml ofmaternal
plasma extracted by QIAamp DNA mini kit according to manufac-
ture’s instruction. DNA was eluted in 60 µl of H2O, 6 µl of DNA
was used for PCR. Reference samples of the mother (blood) and the
father of the baby (saliva) were extracted by QIAamp DNA mini
kit following manufacture’s instruction. Forensic autosomal and
Y chromosome STR were analyzed by using the AmpFlSTR SGM
Plus PCR Amplification Kit (Applied Biosystems, Zug, Switzer-
land) and the Powerplex Y Amplification kit (Promega, Dubendorf,
Switzerland) according to manufacturer’s instruction.
Analysis of DIP–STR Markers’ Performance
To evaluate the discrimination power of DIP–STR markers, we
used real DIP–STR genotypes observed in 103 individuals to simu-
late in silico 5,253 pairwiseDNAmixtures. For each pair of DNA,we
considered both possibilities of major andminor DNA contributors
for a total of 10,506 simulated DNA mixtures. Marker rs35708668-
D5S2045 was eliminated because of the low information content (L
haplotype frequency of 0.04). Based on these data, we counted the
number of markers showing informative genotypes. The DIP–STR
haplotypes of a minor DNA contributor that are nonshared with
the major DNA represents the DNA profile that can be detected
in the mixture. In Table 3 column 1, we summarized these results
by indicating the percentage of simulated DNAmixtures showing a
given minimum number of informative markers.
Alternatively, a theoretical estimate of the DIP–STR informative-
ness is also possible given the fact that the occurrence of informa-
tive genotypes depends on the presence of DIP alleles, which are
unique to the minor DNA contributor. Based on Hardy–Weinberg
assumptions, the probability of informative genotypes (I) at a given
DIP–STR marker can be calculated as I = 2s2l2+2s3l+2sl3 (Fig. 1B).
Where s and l are the frequencies of the S and L alleles, 2s2l2 is the
probability that major and minor DNA contributors are homozy-
gous for the opposite DIP allele (s2l2 +l2s2); whereas, 2s3l+2sl3 are the
probabilities that the major DNA contributor is DIP homozygous
either S or L and the minor DNA contributor is DIP heterozygous,
respectively ([s2[2sl]+ l2[2sl]). The I value for the current nine DIP–
STR markers is reported in Table 2. As average, our markers show
a probability of being informative of 0.32, after the exclusion of the
least polymorphic marker (rs35708668-D5S2045). In Table 3 col-
umn 2, we calculated the theoretical percentage of DNA mixtures
with at least six to 10 informativemarkers by using aDIP–STR panel
of 30 loci. This is based on the cumulative binomial distribution of
30 trials (markers) each one associated to a probability of being
informative (success of the trial) of 0.32. Finally, we calculated the
corresponding match probability of this initial set of markers. For
each informative marker of a simulated DNA mixture (see above),
we considered the frequency of the matching genotypes in the pop-
ulation.When amarker is informative of twominor alleles (Fig. 1A,
“informative genotype 1”), this corresponds to the frequency of the
heterozygous individual in the population. Conversely, when the
marker is informative of only one minor DNA allele (Fig. 1A, “in-
formative genotype 2”), the frequency of the matching genotype
includes the frequency of the corresponding homozygous individ-
ual in addition to all of the possible heterozygous individuals who
carry the observed allele together with any of the DIP opposite hap-
lotypes. Fore each DNA mixture, the results of informative marker
weremultiplied under the assumption of independence ofDIP–STR
haplotypes and unrelated individuals. In the results section, we re-
port a summary of the matching probability distribution calculated
across 10,506 DNA mixtures.
Results
Principle of the Method
To circumvent the problem of the major DNA contributor mask-
ing the minor DNA of a mixture, we propose here a PCR-based
method characterized by allele-specific primers capable of targeting
DNA sequences, which are unique to the minor DNA. These se-
quences are biallelic DIP of few nucleotides, mostly between three
and 15. The two possible alleles are also referred as, long allele (L)
and short allele (S). Because biallelic markers have reduced infor-
mation content, we propose the selection of DIP linked to STR to
form a compound marker termed DIP–STR. The multiallelic hap-
lotype composed of both DIP and STR alleles is analyzed by using
PCR primers overlapping the deleted–inserted sequence on one side
and downstream the STR region on the other side (Fig. 1). Stud-
ies of patterns of human linkage disequilibrium and recombination
hotspots indicate that a distance of few hundred base pairs ensures
the absence of recombination between DIP and STR [Gabriel et al.,
2002; Reich et al., 2001]. The novelty of this marker with respect to
other existing compound genetic markers (SNP–STR for example)
is the use of extended sequence polymorphisms (3–15 bp of the
DIP), which allow the sensitive and specific amplification of the mi-
nor DNA contributor in the presence of large quantities of foreign
DNA background.
For a given DNAmixture, a DIP–STRmarker can be informative
or uninformative depending on the S/L allele mismatch between
the two DNA to be discriminated (Fig. 1A).Whenmajor andminor
DNA are opposite homozygous for the DIP allele, both DIP–STR
haplotypes of the minor DNA can be targeted by allele-specific
PCR. These minor DNA haplotypes may be identical or different
depending on the homozygosity or heterozygosity of the linked STR
(Fig. 1A, “informative genotype 1”). Instead,whenmajor andminor
DNA are homozygous and heterozygous, respectively, for the DIP
alleles, the DIP–STR marker is still informative but the number of
minor DNA haplotype that can be identified is only one (Fig. 1A,
“informative genotype 2”). Conversely, uninformative cases arise
when the minor DNA has no unique S or L allele. This occurs when
major and minor DNA are homozygous for the same DIP allele or
each time the major DNA is heterozygous SL.
DIP–STR List and Haplotype Frequencies
We developed here nine DIP–STR markers characterized by DIP
to STR distance ranging between 213 and 728 bp (Table 1). The
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deleted–inserted sequences range between 3 and 15 bp. Seven STR
are di-nucleotide repeats, one tri-, and one tetra-nucleotide repeats.
Six selected markers span different chromosomes and three are
located on distant regions of chromosome 5 (5q11.2, 5q23.2, and
5q34). In Table 2, we report values of marker variability obtained
from a survey of 103 unrelated Swiss individuals. The alleles of this
compound marker correspond to the observed haplotypes formed
by DIP and STR alleles. The observed heterozygosity range from
0.49 to 0.88. For the nine DIP–STR of Table 2, the number (N) of
observed haplotypes varies between 10 and 19 and the frequencies of
S versus L containing haplotypes are comparable except for marker
rs35708668-D5S2045, where a single L haplotype was observed in
the population surveyed.
PCR Limit of Detection and Specificity Tests
To examine the minimal amount of DNA template required for
successful amplification using S-DIP and STR primers as well as L-
DIP and STRprimers, we amplified serial dilutions ofDNA template
from individuals heterozygous for the DIP allele, regardless the STR
genotype. The corresponding amounts of DNA ranged between 1
and 0.025 ng. The results across the 18 primers pairs (nine S and
nine L DIP–STR amplifications) tested are the following: marker
MID1013-D5S490 S/L, 0.025 ng of minimum amount of DNA
template required for positive amplification; markers rs11277790-
D10S530 S/L, rs60194384-D15S1514 S/L, rs10564579-D3S1282 S/L,
rs35708668-D5S2045 S/L, rs67842608-D5S468 S, and rs66679498-
D2S342 S, 0.1 ng ofDNA template;markersMID1950-D20S473 S/L,
MID1107-D5S1980 S/L, rs67842608-D5S468 L and rs66679498-
D2S342 L, 0.25 ng of DNA template.
Next, we investigated the maximum DNA ratio at which is pos-
sible to amplify the minor DNA in a two-DNA mixture. To do
so, we pooled different quantities of known DNA samples. For each
marker, we used themost challenging informative genotypes, which
occur when a minor DNA heterozygous at the DIP locus is mixed
to a major DNA DIP homozygous (both SS and LL were tested)
(Fig. 1A, “informative genotype 2”) irrespective of the linked STR
alleles. In this case, only one minor DIP–STR haplotype can be se-
lectively amplified. We mixed two DNA contributors at ratios 1:10,
1:20, 1:50, 1:100, and 1:1,000. We successfully amplified the mi-
nor DNA-specific haplotype either S or L for 15 PCR without a
masking effect coming from the major DNA (Fig. 2A). The same
DNA mixture analyzed by a standard forensic kit (NGMselect) al-
lows detecting few minor DNA alleles at a ratio of 1:10 and 1:20.
Conversely, at ratios from 1:50 to 1:1,000, no minor DNA allele can
be detected (Fig. 2B). The S-primers of marker MID1013-D5S490
and rs10564579-D3S1282 produced a nonspecific amplification of
the L allele of the major contributor at DNA ratios below 1:50
and 1:1,000, respectively. And the S-primers of marker rs66679498-
D2S342 show a nonspecific PCR product of constant size close to
the expected range of allele size. Further testing of PCR conditions
including primer design will be necessary for marker multiplexing.
We plan to solve the two issues of PCR specificity and one artifact
during this future technical development.
Examples of Clinical Utility and Feasibility
We tested our new system on two clinical samples representa-
tive of unbalanced DNA mixtures occurring in forensic casework
and peripheral blood DNAmicrochimerism. The forensic case con-
cerned a woman homicide where circumstantial evidence indicated
three suspects; a man and his two sons from different mothers. This
setting allowed us to compare our method to the two most em-
ployed forensic analytical approaches, that is, autosomal STR and
Y chromosome STR. The samples available included a biological
stain collected on the body of the victim and the DNA of three sus-
pects (Fig. 3). We first amplified 1 ng of total DNA obtained from
the mixed stain by using standard autosomal STR multiplex kit. In
Figure 3A,we report themixed stainDNAprofile for the amelogenin
genotype, a forensic marker commonly used to determine the sex of
the DNA donor. This analysis showed one autosomal STR profile,
corresponding to the victim with no indication for the presence of
a male DNA minor contributor (second bin in the electrophero-
gram). However, when we specifically searched for the presence of
male DNA in the stain sample by Y STR markers, we could amplify
one Y chromosome profile corresponding to the three paternally
related suspects. These results show that the quantity of DNA of
the victim is large enough to mask the minor DNA contributor for
standard autosomal loci. Since the victim was a woman, this minor
fraction can be targeted by Y STR, however in this case the suspects
are a father and his two sons. Therefore, the Y profile does not
allow discriminating between them. To solve this issue, we geno-
typed some of the DIP–STR markers of Table 1. In Figure 3B, we
report one informative marker, MID1950-D20S473 as a represen-
tative example. When we amplified 4 ng of DNA extracted from the
mixed stain with S-DIP–STR primers, we detected the haplotypes
12S–13S, which correspond to the victim (major DNA fraction).
Conversely, when we used the L-DIP–STR primers, we detected the
haplotype 12L, which corresponds to the minor DNA contributor
of the mixture. Interestingly, this haplotype matches only one of the
three suspects, suspect number two and excluded the two others.
For this specific case report, theDNAquantity selected forDIP–STR
amplification was decided on the basis of the DNA required for pos-
itive Y chromosome amplification. The development of a specific
DIP–STR quantification scheme for forensic applications could be
useful.
The peripheral blood DNA microchimerism examples comprise
two plasma samples from women at 30 and 36 weeks of pregnancy
(Fig. 4). Knowing that the two developing babies were males, we
used the Y STR markers for resolving the DNA mixture (data not
shown).We further analyzed these samplesbyusingDIP–STRmark-
ers and report here two informative results. The first plasma sam-
ple was analyzed by marker MID1950-D20S473 by using S-DIP–
STR primers (Fig. 4A). The second plasma sample was analyzed by
marker rs66679498-D2S342 (Fig. 4B) by using L-DIP–STR primers.
In both plasma samples, we found that DIP–STR genotyping did
detect the autosomal fetal haplotype transmitted from the father to
the child.While this shows that our system has equal sensitivity than
Y-STR for males, its principal advantage is that based on targeting
autosomal sequences, it enables the analysis of fetal DNA for any
sex of the baby.
Analysis of DIP–STR Markers’ Performance
Although we tested with success our DIP–STR method on repre-
sentative clinical samples, a formal evaluation of the performance of
the developedDIP–STRmarkers ismandatory.Here, we empirically
estimated the probability of finding informative markers on DNA
mixtures simulated by using real DIP–STR genotypes observed in
103 Swiss individuals (marker rs35708668-D5S2045 was eliminated
because of low information content, seeMethods). Over the analysis
of 10,506 in silico simulated pairwise DNAmixtures, we found that
5% of themixtures have zero informativemarkers, 95% have at least
HUMANMUTATION, Vol. 34, No. 4, 644–654, 2013 649
Figure 3. A clinical example of forensic mixed stain analysis by DIP–STR genotyping. A: Portion of the autosomal standard STR amplification
(SGM plus kit) profile corresponding to the marker used for the sex determination, amelogenin. The unique peak indicates that no male DNA is
detected in the mixed stain. The complete STR profile corresponds to the victim. The presence of a second minor DNA contributor of the mixture
corresponding to a male was assessed by Y STR genotyping (data not shown). B: Data of one informative DIP–STR marker, MID1950-D20S473 used
to discriminate between the three paternally related suspects. On the left side are the genotypes of the DNA available for comparison. On the right
side, we reported the electropherograms of the mixed stain analysis when amplified by S-DIP–STR primers (upper panel) and the by L-DIP–STR
primers (middle panel). The results 12S–13S of the mixed stain correspond to the DNA of the victim, while, the result 12L represents the detection of
the minor DNA contributor of the mixture. Interestingly, this genotype is compatible with only one of the three suspects, suspect number 2 (lower
panel).
one informativemarker, 76% have at least two informativemarkers,
and 47% at least three informative markers (Table 3 column 1).
Since the chances of having informative anduninformativemark-
ers depend on the occurrence of DIP alleles unique to the mi-
nor DNA, we can calculate this probability (I) by the function:
I = 2s2l2+2s3l+2sl3 (see Methods and Fig. 1B). This function has a
maximum at s = l = 0.5 where I = 0.375. The curve slowly decrease,
at minor allele frequency (MAF) = 0.4 I = 0.365, and MAF = 0.3
I = 0.332. This means that given similar allele frequencies of S and L
alleles, roughly one third of the cases will show an informative geno-
type. The I value for the current nine DIP–STR markers is reported
in Table 2. As average ourmarkers show a probability of being infor-
mative of 0.32, after the exclusion of the least polymorphic marker.
This value can be used to determining the percentage of DNA mix-
tures showing a given minimum number of informative markers
with respect to the size of the DIP–STR panel used (see Methods).
In Table 3 column 2, we calculated this percentage assuming the
use of 30 DIP–STR markers of allele frequencies similar to the ones
already developed (I = 0.32). The results indicate 95% of DNAmix-
tures with at least six informative markers, 79% with at least eight
informative markers, and 50%with at least 10 informative markers.
Finally, for the eight markers described, we calculated the expecta-
tion on match probabilities based on the simulated DNA mixture
data. The index of match probability is used mainly in forensics to
express the probability of a random match between two DNA. The
simplest estimate of the random match probability expected for an
observed genotype corresponds to the frequency of the genotype in
the population. In our estimates, we took into account the fact that
DIP–STR can be fully (Fig. 1A, “informative genotype 1”) or par-
tially informative (Fig. 1A, “informative genotype 2”) and therefore
one frequency or multiple frequencies corresponding to all possi-
ble compatible genotypes were considered (seeMethods). We found
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Figure 4. Clinical examples of pregnancy induced DNA microchimerism analysis by DIP–STR genotyping. A: DIP–STR amplification of marker
MID1950-D20S473 using the S-specific primer on the trio, mother 1 (saliva), child 1 (maternal plasma sample drawn at 30 weeks of pregnancy) and
father 1 (saliva). B: DIP–STR amplification of marker rs66679498-D2S342 using the L-specific primer on a different trio, mother 2 (saliva), child 2
(maternal plasma sample drawn at 36 weeks of pregnancy), and father 2 (saliva). The electropherograms show the detection in the maternal blood
of the DIP–STR haplotypes transmitted from each father to the child. N; not determined.
that 20% of simulated DNA mixtures show a minor DNA match
probability between 1 and 1/10; 25% between 1/11 and 1/100; 24%
between 1/101 and 1/1,000; 16% between 1/1,001 and 1/10,000 and
15% more than 1/10,000. (A more detailed analysis of the forensic
value of the current DIP–STR will be the topic of a future arti-
cle). Taken together, we provide examples of eight highly sensitive,
specific, and informative DIP–STR markers for unbalanced DNA
mixture analysis.
Discussion
In this study, we propose theDIP–STR as a newmolecularmarker
for the analysis of unbalanced DNAmixtures. This new tool is char-
acterizedby the followingkey features: (1) high sensitivity for detect-
ing the minor DNA component of a mixture (DNA ratio 1:1,000)
under informative genotypes; (2) capacity of targeting the minor
DNA regardless of the sex of the contributors; (3) high discrimi-
nation power for identity testing; finally (4) simple and low-cost
genotyping technique. The attractive features of this type of genetic
marker reside on its compound nature: the 3–15 bp sequence poly-
morphisms (DIP) located close to the STR allows designing highly
specific PCR primers that can target in a robust way the amplifica-
tion of a minor DNA contributing less than 0.1% to a mixture.
Applications of this method include the analysis of mixed stains
for forensic purposes as well as the analysis of peripheral bloodDNA
microchimerismsduringpregnancy and followingorgan transplant.
Our results suggest that both types of DNAmixtures can be resolved
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by DIP–STR analysis. In the reported clinical examples, we show
that standard molecular methods either fail (autosomal STR) or
provide data that are less informative (Y STR). For example, in
the forensic case report, we were able to detect the presence of
a minor DNA contributor of a mixed stain while autosomal STR
failed. Additionally, we successfully discriminated among the three
potential contributors of the minor DNA (suspects of the crime),
while these cases could not be resolved by Y STR analysis, because
paternally related. The expectation on match probabilities of this
initial set of DIP–STR roughly corresponds to the values one can
expect by using Y STRmarkers. Although these markers are capable
of amplifying a minor DNA that is otherwise loss under major
alleles, stutters, and background noise, a larger set of DIP–STR is
required to obtain match probabilities comparable to autosomal
STR profiling.
The suitability of the method for peripheral blood DNA mi-
crochimerism detection was demonstrated by the analysis of two
plasma samples drawn from women at 30 and 36 weeks of preg-
nancy. In these sample analysis, our markers performed as well as
the Y STR with the advantage of being able to detect both male
and female developing babies. The last clinical examples confirmed
the performance of our molecular assay on in vivo DNA mixtures.
However, the contribution of our method to prenatal genetics will
be assessable once samples from early gestational age (8–10 weeks)
are included, as this stage is the most relevant for a better handling
of the diagnosis of a genetic condition. In this context, previous
reports indicate that the DNA microchimerism generated in the
maternal blood during pregnancy is due to fetal cell turnover events
occurring during the formation of the placenta [Lo et al., 1998; Tjoa
et al., 2006]. The estimated quantity of fetal DNA varies between
3% and 6% of the total cell-free DNA in maternal circulation dur-
ing early and late pregnancy [Lo et al., 1998]. Based on these data,
we expect that DIP–STR will detect the DNA of the baby even in
early pregnancy despite the slight reduction of the expected DNA
quantity. Analytical methods capable of detecting the fetal DNA
circulating in maternal blood can be used for developing prenatal
tests including sex determination, paternity tests [Guo et al., 2012]
(largely demanded in case of pregnancy after a sexual assault) and
possibly diagnostic tests for specific genetic diseases. Besides allow-
ing an earlier prenatal diagnosis, the use of noninvasive techniques
eliminates the risk of fetal miscarriage associated to amniocentesis
or chorionic villus sampling.
Similarly, in solid organ transplant DIP–STR development may
identify noninvasive transplant surveillance biomarkers. When an
individual is transplanted of an organ, shortly after the operation,
traces of DNA of the donor can be detected in the blood of the
recipient (and in urine for kidney transplantation) [Chok et al.,
2002]. Several studies suggest that this phenomenon is caused by
apoptotic events of specific cell types within the allograft. Therefore,
the detection and longitudinal quantification of the donor’s DNA
in the blood of the recipient may correlate to the incidence of acute
rejection [Gadi et al., 2006; Moreira et al., 2009; Pujal and Gallardo,
2008]. The relevance of the contribution of DIP–STR to this field
resides on the fact that current methods for the diagnosis of graft
injury still require invasive biopsies, and detectable pathological
changes can be associated to advanced stages of allograft damage.
For purposes of transplant monitoring, the quantitative feature of
the assay rather than the identification power becomes relevant
(the donor’s alleles are known). In this respect, real-time PCR can
be used to quantity of donor’s DNA per milliliter of plasma. To
compare several measures at different time points, the efficiency
of the DNA extraction process needs to be normalized. To do so,
an exogenous DNA can be spiked into the plasma, next it can be
extracted and amplified togetherwith the extracellularDNA. Several
synthetic DNA exist on the market, of various lengths, provided of
real time PCR primers.
Although we provide a proof of principle study, including an ini-
tial set of novel genetic markers, their applications to two clinical
examples and performance studies; in practice, the contribution
of DIP–STR to each field will depend on the further development
of additional markers characterized by the following features: first,
the DIP to STR distance should be about 200–300 bp to assure
the feasibility of DNA analysis of degraded samples and of extra-
cellular DNA generated by necrosis and apoptotic events; second,
markers should be located on different chromosomes or different
chromosomal arms to ensure independence of transmission for a
maximumprobative value; tri-, tetra-, penta-, hexa-nucleotideDIP-
linked STR should be preferred to di-nucleotide STR because of the
reduced problem of PCR stutters; fourth, for forensic applications,
DIP–STR markers should be based on large population survey and
family trios to select them universal and outside recombination
hot-spots; fifth, for prenatal disease diagnosis, genetic markers can
be used to determine the paternal transmission of a mutation re-
sponsible in one or two copies of a single-gene disorder. To do this,
selected DIP–STR should avoid recombination hotspots to allow
tracking the paternal transmission with certainties; however, these
markers do not need to be linked to the disease mutation in the
general population. Finally, the appropriate statistical frame should
be developed for each application (the forensic statistical frame for
the analysis of DIP–STR is the topic of a submitted research article).
With the aim of developing a proof-of-concept panel, here we
show a limited set of markers of various features to prove themolec-
ular feasibility of the method and provide the theoretical basis and
guidelines for newmarker development. It should be noted that the
markers described were searched among well-characterized STR
polymorphisms genotyped in several populations (7,469 STR) and
DIP polymorphisms were obtained from a previous track (SNP131)
of the variations and repeats UCSC database. These criteria resulted
in an undersized list of candidateDIP–STR in the genome (70mark-
ers). However, the initial analysis of the draft sequence of the human
genome concluded that more than one million STR may be present
depending on how they are counted [Ellegren, 2004] with 10,000
commonly used for genetic linkage and association studies. The dis-
covery of DIP is less advanced; however, Mills and colleagues [Mills
et al., 2006, 2011] described 1.36 million DIP in the genome, the
majority smaller than 100 bp insertion–deletion, with an average
distance location of 1.6 kb. Therefore, these studies support an a
priori chance of finding enough DIP-linked STR that satisfies most
of the aforementioned selecting criteria. To give a better feel of the
likelihood of finding additional DIP–STR in the genome, we further
explored the UCSC genome database and we searched for candidate
DIP and STR polymorphisms matching the above-discussed guide-
lines. We search only over noncoding regions, far at least 500 bp
a 3′end and 2,000 bp a 5′end of a coding sequence; simple repeats
of unit length between three and six nucleotides with at least 10
repetitions to increase the chance of polymorphic STR. DIP were
searched among polymorphisms annotated as indels, deletion, or
insertions of 3–10 bp. Before assessing the linked markers between
these two lists, we eliminated those indels that are also labeled as
simple repeats and we merged redundant simple repeats annota-
tions corresponding to the same repetitive sequence region. Based
on these selecting criteria, we found 2,570 candidate DIP–STR be-
tween 25 and 200 bp apart, and 6,533 up to 500 bp apart, spanning
evenly the genome from chromosomes 1 to 22. Their density should
allow choosing a set of variable DIP–STR markers unlinked to each
other and far from recombination hotspots. Conversely, available
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DIP databases currently do not offer the choice of DIP linked to
consensus STR (ENFSI/CODIS loci) to allow database DNA pro-
file search and cold-case resolution. Thus, a special effort should
be put in defining new forensic databases, which include DIP–STR
genotypes.
A caveat of this method that merits an extensive discussion is
the risk of having DIP–STR genotypes, which are uninformative
for mixture resolution. More specifically, the DIP–STR target am-
plification of the minor DNA is limited to those haplotypes that
contain DIP alleles, which are not shared with the major DNA. It
follows that, when the DIP genotype is uninformative (all minor
DNA DIP alleles are shared with the major DNA), the resolution of
the technique is the same as for standard STR markers. This limit
is compensated by the use of a relatively large panel of DIP–STR,
which increases the chance of finding alleles unique to the minor
DNA, in a range that is useful in practice. It should be noted that
DIP–STRmarkers may be advantageous over standard STR analysis
even for the analysis of mixtures of two DNA in equal proportions.
This is because DIP–STR allow attributing to each DNA fraction
the STR alleles that are shared between the two contributors, given
that they can be targeted by S- or L-specific amplifications. The
question is now, how large should be an analytical DIP–STR panel?
Under similar S andL allele frequencies, theminorDNAcontributor
is expected to have one or two detectable haplotypes (informative
markers) in about one third of the genotyped markers (see Results).
From here, we can extrapolate that the use of 30 markers character-
ized by a probability of being informative of 0.32 (similar to the eight
preliminary DIP–STR developed), we obtain 95% of DNAmixtures
with at least six informativemarkers and 50%ofDNAmixtures with
at least 10 informative markers. The precise number of markers to
be genotyped will depend on the degree of polymorphism of the
selected analytical panel and on the purpose of the DNA analysis.
Another foreseen valuable forensic application of the method
is the screening of a complex DNA mixture for the presence of an
individual following amass disaster (DVI cases). Thedesignof a very
large panel of DIP–STR composed of rare DIP alleles can be used
for searching a minor DNA in a complex DNA mixture. A similar
issue by using rare SNPs was evaluated and developed theoretically
[Voskoboinik andDarvasi, 2011]. In this respect, DIP–STR offer the
advantage of being capable of detecting the presence of an individual
in a complex mixture even when its contribution is less than 0.1%
in quantity.
Finally, DIP–STR may also impact studies on human demog-
raphy and population structure. This is because nonrecombining
haplotypes composed of both slow-evolving markers (DIP) and
fast-evolving markers (STR) combine the benefits of both tools
[de Knijff, 2000; Mountain et al., 2002]. Described in simple terms,
the instability of the STRs results in formation of many alleles pro-
portional to the population divergence time and the stable flanking
DIP marker allows greater certainty in tracing the lineage of each
haplotype. As opposite to forensic panel, markers informative of
population history show large allele frequency differences across
populations including alleles, which are specific of a demographic
group.
Conclusions
DIP–STR should provide forensic scientists with a powerful tool
for the investigation of a particular and yet frequent type of sample
that nowadays remains unsolved. The standard technical require-
ments for themolecular analysis of aDIP–STR, and the planned the-
oretical development, will allow readily introduction of the method
to forensic laboratories; however, entirely new or additional DIP–
STRmarkerswill need to be developed for each specific applications.
Moreover, this new tool should allow the development of a powerful
noninvasive methodological approach to tackle emerging medical
questions such as, prenatal paternity tests, organ transplant moni-
toring, and prenatal disease diagnosis.
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